Search results for: Antibiotics
Filter search results
Additional Elements of Value for Health Technology Assessment Decisions
1 May 2017
…when microorganisms such as bacteria, viruses, fungi and parasites change in ways that render the medications used to cure the infections they cause ineffective. Without new antibiotics, more patients will…
OHE at ISPOR Europe 2023
13 November 2023, 12:00am
…Poster Session Time: 10:30 – 13:30 Discussion Period: 12:30 – 13:30 Poster Session Is Stedi Steady? an Exploration of the Uncertainties Underlying the Quantification of the Broader Value of Antibiotics…
OHE at HTAi Rome
12 July 2017
…drugs is a wide-spreading medical threat. OHE has also recently published a related Briefing, entitled: Assessing the Value of New Antibiotics: Additional Elements of Value for Health Technology Assessment Decisions….
The Dynamics of Drug Shortages
9 January 2024
…Oncology, 24, pp.v17–v22. 10.1093/annonc/mdt324. Eversana, 2022. English Pharmacies Making a Loss When Dispensing Strep A Antibiotics, Amid Surge in Infections. Navlin Daily. Available at: https://www.navlindaily.com/article/15115/english-pharmacies-making-a-loss-when-dispensing-strep-a-antibiotics-amid-surge-in-infections [Accessed 7 Jun. 2023]. Francois, C., Gawlik,…
Cost and Benefits of Pharmaceutical Research
1 May 1987
…medical research in this context means pharmaceutical research. Almost all the medical progress since 1948 has been made possible by advances in pharmacology – antibiotics, anaesthetics, muscle relaxants, and immuno-suppressant…
Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help?
1 October 2017
…On the one hand, bad practice favours the spread of infections, such as overuse of antibiotics in human and veterinary care, and poor prevention and hygiene practices. On the other…
Assessing the Productivity Value of Vaccines in Health Technology Assessment: Worth a Shot?
17 September 2020
…announced a pilot programme of a ‘volume-delinked’ payment scheme, which will include a modified assessment approach of antibiotics. 6 It should be noted that NICE has no experience so far of assessing…
Antibacterials: Roundtable Addresses the Critical Issues
10 November 2011
…raised included the danger of stewardship being a screen for anticompetitive behavior, the need to include generics, and the possibility of a tax on newly-generic antibiotics to raise funds for…
Pharmacogenomics Testing: A Crucial Piece to Unlocking the Full Value of Medicines
5 June 2025
…ADRs and treatment ineffectiveness, PGx testing can be used to inform prescribing decisions. PGx testing guidelines exist for many commonly prescribed medicines, including blood thinners, antibiotics, and anti-cancer agents. Internationally…